A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine
Abstract Yellow fever, a mosquito-borne flavivirus infection, is an important public health problem in Africa and Latin America. A Yellow Fever vaccine (YFV) was developed and tested in a study in India. This was a Phase I, open-label, randomized, controlled study where healthy adults received SII Y...
Main Authors: | Sajjad Desai, K. Anil, Anirudha Vyankatesh Potey, Y. Sindhu, Silvia Grappi, Giulia Lapini, Satyaprasad Manney, Parikshit Tyagi, Emanuele Montomoli, Cyrus S. Poonawalla, Prasad S. Kulkarni |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-12-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-022-00595-6 |
Similar Items
-
Yellow Fever: Origin, Epidemiology, Preventive Strategies and Future Prospects
by: Elena Gianchecchi, et al.
Published: (2022-02-01) -
Yellow fever
by: Prata Aluízio
Published: (2000-01-01) -
Yellow fever
by: Aluízio Prata
Published: (2000-01-01) -
Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal models
by: Lex G. Medina-Magües, et al.
Published: (2023-03-01) -
Post-marketing safety surveillance of the rotavirus vaccine in India
by: Gagandeep Kang, et al.
Published: (2023-12-01)